Literature DB >> 29626232

A pre-meal of whey proteins induces differential effects on glucose and lipid metabolism in subjects with the metabolic syndrome: a randomised cross-over trial.

Ann Bjørnshave1,2, Jens Juul Holst3, Kjeld Hermansen4.   

Abstract

PURPOSE: Postprandial lipaemia (PPL), an independent risk factor for cardiovascular disease, is affected by composition and timing of meals. We evaluated if whey proteins (WP) consumed as a pre-meal before a fat-rich meal reduce postprandial triglyceride (TG) and apolipoprotein B-48 (ApoB-48) responses in subjects with the metabolic syndrome (MeS).
METHODS: An acute, randomised, cross-over trial was conducted. 20 subjects with MeS consumed a pre-meal of 0, 10 or 20 g WP 15 min prior to a fat-rich meal. The responses of TG and ApoB-48 were assessed. We also analysed postprandial responses of free fatty acids (FFA), glucose, insulin, glucagon, glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP) and paracetamol (reflecting gastric emptying rates).
RESULTS: WP pre-meal did not alter the TG or ApoB-48 responses. In contrast, the insulin response was more pronounced after a pre-meal of 20 g WP than with 10 g WP (P = 0.0005) and placebo (P < 0.0001). Likewise, the postprandial glucagon response was greater with a pre-meal of 20 g WP than with 10 g WP (P < 0.0001) and 0 g WP (P < 0.0001). A pre-meal with 20 g of WP generated lower glucose (P = 0.0148) and S-paracetamol responses (P = 0.0003) and a higher GLP-1 response (P = 0.0086) than placebo. However, the pre-meal did not influence responses of GIP, FFA or appetite assessed by a Visual Analog Scale.
CONCLUSIONS: Consumption of a WP pre-meal prior to a fat-rich meal did not affect TG and chylomicron responses. In contrast, the WP pre-meal stimulates insulin and glucagon secretion and reduces blood glucose as expected, and delays gastric emptying. Consequently, our study points to a differential impact of a WP pre-meal on lipid and glucose metabolism to a fat-rich meal in subjects with MeS.

Entities:  

Keywords:  Dose–response; Metabolic syndrome; Postprandial lipaemia; Pre-meal; Whey proteins

Mesh:

Substances:

Year:  2018        PMID: 29626232     DOI: 10.1007/s00394-018-1684-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  5 in total

1.  Effects of low doses of fish and milk proteins on glucose regulation and markers of insulin sensitivity in overweight adults: a randomised, double blind study.

Authors:  Ida Heir Hovland; Ingrid Sande Leikanger; Oddbjørg Stokkeland; Kaia Hevrøy Waage; Svein A Mjøs; Karl A Brokstad; Adrian McCann; Per Magne Ueland; Rasa Slizyte; Ana Carvajal; Gunnar Mellgren; Tore Remman; Ingmar Høgøy; Oddrun A Gudbrandsen
Journal:  Eur J Nutr       Date:  2019-04-10       Impact factor: 5.614

2.  Pre-meal protein intake alters postprandial plasma metabolome in subjects with metabolic syndrome.

Authors:  Ceyda Tugba Pekmez; Ann Bjørnshave; Giulia Pratico; Kjeld Hermansen; Lars Ove Dragsted
Journal:  Eur J Nutr       Date:  2019-07-06       Impact factor: 5.614

Review 3.  Diet and Healthy Lifestyle in the Management of Gestational Diabetes Mellitus.

Authors:  Louise Rasmussen; Charlotte Wolff Poulsen; Ulla Kampmann; Stine Bech Smedegaard; Per Glud Ovesen; Jens Fuglsang
Journal:  Nutrients       Date:  2020-10-06       Impact factor: 5.717

4.  Whey protein consumption following fasted exercise reduces early postprandial glycaemia in centrally obese males: a randomised controlled trial.

Authors:  Dean M Allerton; Daniel J West; Emma J Stevenson
Journal:  Eur J Nutr       Date:  2020-06-22       Impact factor: 5.614

Review 5.  The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go.

Authors:  Kieran Smith; Kelly A Bowden Davies; Emma J Stevenson; Daniel J West
Journal:  Front Nutr       Date:  2020-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.